Logo

Roche Avenio Tumor Tissue Comprehensive Genomic Profiling Kit

Oct 25, 2021

Roche has launched its Avenio Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit for research use. The jointly developed project from Roche and Foundation Medicine delivers information about complex genomic signatures, including tumor mutational burden, microsatellite instability, and loss of heterozygosity, in addition to a comprehensive genomic panel. It provides an end-to-end next-generation sequencing workflow including DNA extraction and library preparation, and delivers results by the FoundationOne Analysis Platform via Avenio Connect.

The kit's gene panel is drawn from the FoundationOne companion diagnostic panel, analyzing 324 cancer-related genes across four main classes of genomic alterations and genomic signatures. It is configured to run 24 samples with results in five days on Illumina's NextSeq 500/550 RUO and NextSeq 550 Dx System in research mode.

The kit is intended for laboratories to use in house and will launch in Europe, North America, Asia, and South America.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.